"We are proud to be partnering with one of the largest consumer products companies in the world to create differentiated products for their portfolio. The ability to add novel products to their extensive offering will provide patients the choice and flexibility they need to ease administration challenges," said Maria Flynn, CEO and President of Orbis Biosciences.
"We are very excited to partner with the Orbis Biosciences talented team to strengthen further our innovation pipeline in strategic areas of our leading consumer health relief portfolio. At RB, we believe that vibrant partnerships are critical in delivering RB purpose of innovative solutions for Healthier Lives and Happier Homes," said Laurent Faracci, Executive VP Category Development for RB Health.
Highlights:
- Licensed fields cover select active ingredients in the $45B over-the-counter market
- Licensed territory is worldwide
About Reckitt Benckiser
RB is the global leading consumer health and hygiene company. Driven by a purpose of providing innovative solutions for healthier lives and happier homes, RB has operations in over 60 countries. From the foundations of wellness and infant nutrition, to the fundamentals of a hygienic home, its global brands help people live healthier, happier lives. RB has world leading Powerbrands which include household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick.
.svg)
